Serotonin Centers, the nation’s fastest-growing anti-aging/longevity franchise, announced the appointment of Dr. Lisa Golding-Granado to the role of Chief Medical Officer. The move marks a significant stride forward as Serotonin is rapidly rising up as the nation’s leading franchise of personalized anti-aging and longevity treatments.

Dr. Golding-Granado, a graduate from Cornell University Medical College, has spent 24 years in the medical space as a board-certified doctor of internal medicine. She first became involved with Serotonin back in 2022, having signed on to become the first franchisee in New Jersey. Her interest in preventative medicines and anti-aging treatments prompted her business venture into the anti-aging arena under the Serotonin brand.

As Chief Medical Officer, Dr. Golding-Granado will advise and serve as a resource to the medical directors and practitioners staffing each of the brand’s locations; assuring exceptional medical care across the franchise system. In her role, she will also be tasked with ensuring the highest standards of client care, safety, and results.

“With my passion for preventative medicine, I was inspired by Serotonin’s mission to help people feel better and improve their health span. That’s what originally inspired me to open my own Serotonin Centers franchises,” Dr. Golding-Granada said. “Now, by also taking on the role as Chief Medical Officer for the brand, I’ll be able to help other franchisees further carry out the Serotonin Centers’ mission by providing support and guidance to their medical staff, and ensuring best practices, while maximizing client outcomes.”

With 100 franchises open or under development, Serotonin is positioned to lead the MedSpa and anti-aging industries as demand in the sector continues to escalate.